These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Major Changes in 2021 World Health Organization Classification of Central Nervous System Tumors. Kurokawa R; Kurokawa M; Baba A; Ota Y; Pinarbasi E; Camelo-Piragua S; Capizzano AA; Liao E; Srinivasan A; Moritani T Radiographics; 2022; 42(5):1474-1493. PubMed ID: 35802502 [TBL] [Abstract][Full Text] [Related]
23. The 2021 WHO Classification for Gliomas and Implications on Imaging Diagnosis: Part 3-Summary of Imaging Findings on Glioneuronal and Neuronal Tumors. Park YW; Vollmuth P; Foltyn-Dumitru M; Sahm F; Choi KS; Park JE; Ahn SS; Chang JH; Kim SH J Magn Reson Imaging; 2023 Dec; 58(6):1680-1702. PubMed ID: 37715567 [TBL] [Abstract][Full Text] [Related]
24. 2016 World Health Organization Classification of Central Nervous System Tumors. Wen PY; Huse JT Continuum (Minneap Minn); 2017 Dec; 23(6, Neuro-oncology):1531-1547. PubMed ID: 29200109 [TBL] [Abstract][Full Text] [Related]
25. WHO CNS5 2021 classification of gliomas: a practical review and road signs for diagnosing pathologists and proper patho-clinical and neuro-oncological cooperation. Sejda A; Grajkowska W; Trubicka J; Szutowicz E; Wojdacz T; Kloc W; Iżycka-Świeszewska E Folia Neuropathol; 2022; 60(2):137-152. PubMed ID: 35950467 [TBL] [Abstract][Full Text] [Related]
26. Applications of molecular neuro-oncology - a review of diffuse glioma integrated diagnosis and emerging molecular entities. Wood MD; Halfpenny AM; Moore SR Diagn Pathol; 2019 Apr; 14(1):29. PubMed ID: 30967140 [TBL] [Abstract][Full Text] [Related]
27. The 2021 WHO Classification for Gliomas and Implications on Imaging Diagnosis: Part 1-Key Points of the Fifth Edition and Summary of Imaging Findings on Adult-Type Diffuse Gliomas. Park YW; Vollmuth P; Foltyn-Dumitru M; Sahm F; Ahn SS; Chang JH; Kim SH J Magn Reson Imaging; 2023 Sep; 58(3):677-689. PubMed ID: 37069792 [TBL] [Abstract][Full Text] [Related]
28. Beyond the World Health Organization classification of central nervous system tumors 2016: what are the new developments for gliomas from a clinician's perspective? Weller M; Reifenberger G Curr Opin Neurol; 2020 Dec; 33(6):701-706. PubMed ID: 33177376 [TBL] [Abstract][Full Text] [Related]
29. A Practical Approach to the Evaluation and Diagnosis of Pediatric CNS Tumors. Cotter JA; Viaene AN; Santi M; Hawkins C; Judkins AR Pediatr Dev Pathol; 2022; 25(1):6-9. PubMed ID: 33872110 [TBL] [Abstract][Full Text] [Related]
30. The World Health Organization Classification of Tumors of the Central Nervous System, Fifth Edition, 2021: A Critical Analysis. Miller DC Adv Tech Stand Neurosurg; 2023; 46():1-21. PubMed ID: 37318567 [TBL] [Abstract][Full Text] [Related]
31. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Louis DN; Perry A; Reifenberger G; von Deimling A; Figarella-Branger D; Cavenee WK; Ohgaki H; Wiestler OD; Kleihues P; Ellison DW Acta Neuropathol; 2016 Jun; 131(6):803-20. PubMed ID: 27157931 [TBL] [Abstract][Full Text] [Related]
32. The Essentials of Molecular Testing in CNS Tumors: What to Order and How to Integrate Results. Feldman AZ; Jennings LJ; Wadhwani NR; Brat DJ; Horbinski CM Curr Neurol Neurosci Rep; 2020 May; 20(7):23. PubMed ID: 32445025 [TBL] [Abstract][Full Text] [Related]
33. Proton MR spectroscopy shows improved performance to segregate high-grade astrocytoma subgroups when defined with the new 2021 World Health Organization classification of central nervous system tumors. Majós C; Pons-Escoda A; Naval P; Güell A; Lucas A; Vidal N; Cos M; Bruna J Eur Radiol; 2024 Apr; 34(4):2174-2182. PubMed ID: 37740778 [TBL] [Abstract][Full Text] [Related]
34. DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas. Paul Y; Mondal B; Patil V; Somasundaram K Clin Epigenetics; 2017; 9():32. PubMed ID: 28392842 [TBL] [Abstract][Full Text] [Related]
35. [Classification and Diagnostics of Pediatric Brain Tumors]. Kanemura Y No Shinkei Geka; 2023 Sep; 51(5):778-788. PubMed ID: 37743329 [TBL] [Abstract][Full Text] [Related]
36. Classification of adult-type diffuse gliomas: Impact of the World Health Organization 2021 update. Whitfield BT; Huse JT Brain Pathol; 2022 Jul; 32(4):e13062. PubMed ID: 35289001 [TBL] [Abstract][Full Text] [Related]
37. Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery. Cimino PJ; Zager M; McFerrin L; Wirsching HG; Bolouri H; Hentschel B; von Deimling A; Jones D; Reifenberger G; Weller M; Holland EC Acta Neuropathol Commun; 2017 May; 5(1):39. PubMed ID: 28532485 [TBL] [Abstract][Full Text] [Related]
38. Glial and glioneuronal tumors: Navigating the complexity of evolving concepts and new classification. Han PC; Baker TG J Neurol Sci; 2024 Jun; 461():123058. PubMed ID: 38781807 [TBL] [Abstract][Full Text] [Related]
39. Grading of adult diffuse gliomas according to the 2021 WHO Classification of Tumors of the Central Nervous System. Komori T Lab Invest; 2022 Feb; 102(2):126-133. PubMed ID: 34504304 [TBL] [Abstract][Full Text] [Related]
40. Utility of genome-wide DNA methylation profiling for pediatric-type diffuse gliomas. Otani Y; Satomi K; Suruga Y; Ishida J; Fujii K; Ichimura K; Date I Brain Tumor Pathol; 2023 Apr; 40(2):56-65. PubMed ID: 37004583 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]